Alfa Aesar, a Johnson Matthey company, has published a new High Purity Metals and Materials Catalog which highlights Alfa Aesar's entire range of metals and alloys from aluminum to zirconium, featuring purities up to 99.9999%.
Broadcom Corporation, a global leader in semiconductors for wired and wireless communications, today announced the industry's first family of 65 nanometer (nm) 10 Gigabit (10G) physical layer (PHY) devices that support data rates ranging from 9.953 Gigabits per second (Gbps) to 11.35 Gbps.
Thermo Fisher Scientific Inc. today announced it will showcase its comprehensive laboratory instrumentation and informatics solutions for food, beverage and agricultural applications at the 2008 Association of Analytical Communities (AOAC) annual meeting and exposition.
Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced today that the European Patent Office (EPO) has issued Patent No. 1744789 to the Company, related to its 'novel activable particles that can be used in the health sector'.
This new relationship combines Ferro's extensive sales network and leading performance materials supplier position in the glass and ceramic industries with Nanofilm's technology platforms and experience in formulating thin films for a wide range of substrates and surfaces.
Dr. Scott Rickert, President and CEO of Nanofilm, will address the topic 'The Next Wave in Nanotechnology' as part of the World Economic Forum Annual Meeting of the New Champions, September 25-27, in Tianjen, China.
DuPont India today announced the opening of the first research facility at the DuPont Knowledge Center (DKC) in Hyderabad. The Biotech Research Center begins its operations with more than 80 scientists working on a variety of global research programs on plant and industrial biotechnology.
GE Global Research, the technology development arm for the General Electric Company, announced a two-year cooperative research and development agreement with the National Cancer Institute (NCI) to accelerate the development of cutting-edge nanoparticle based imaging agents that have the potential to revolutionize the diagnosis and treatment of cancer and heart disease.
NanoH2O, Inc., developer of next generation reverse osmosis membranes for desalination and water reuse, today announced that it has secured $15 million in funding from Oak Investment Partners and Khosla Ventures.
BioAlliance Pharma SA, the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and AIDS, today announced that Madame Dominique Costantini, President of the company's Executive Board, had been awarded the Knight of the Legion of Honor insignia.
Applied Nanoscience Inc. today announced that it has committed to fully assist its future merger partner Emergency Filtration Products, Inc. (EFP) in the response to comments issued by the FDA in relation to the 510(k) pre-market notification filed by EFP in connection with the NanoMask.
A key focus of this Consortium is on developing tools and protocols that bridge the gap between atomistic simulations and engineering applications in the area of reaction kinetics. In particular, the software toolset is being extended to provide chemical engineering parameters such as rate constants, and enable engineering and molecular approaches to connect via methods such as Kinetic Monte Carlo.